Researchers at Taipei’s Veterans General Hospital report that Parp1 regulates nuclear reprogramming and promotes iPSC generation with reduced risk of carcinogenic side effects
China Bio news release, October 6, 2013
Taiwan researchers claim breakthrough in iPS differentiation